%0 Journal Article
%T Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group
%A Chingching Foocharoen
%A Alan Tyndall
%A Eric Hachulla
%A Edoardo Rosato
%A Yannick Allanore
%A Dominique Farge-Bancel
%A Paola Caramaschi
%A Paolo Air¨®
%A Starovojtova M Nikolaevna
%A Jos¨¦ Pereira da Silva
%A Bojana Stamenkovic
%A Gabriela Riemekasten
%A Simona Rednic
%A Jean Sibilia
%A Piotr Wiland
%A Ingo Tarner
%A Vanessa Smith
%A Anna T Onken
%A Walid Abdel Atty Mohamed
%A Oliver Distler
%A Jadranka Morovi£¿-Vergles
%A Andrea Himsel
%A Paloma de la Pe£¿a Lefebvre
%A Thomas H¨¹gle
%A Ulrich A Walker
%J Arthritis Research & Therapy
%D 2012
%I BioMed Central
%R 10.1186/ar3748
%X This study was carried out prospectively in the multinational EULAR Scleroderma Trial and Research database by amending the electronic data-entry system with the International Index of Erectile Function-5 and items related to ED risk factors and treatment. Centres participating in this EULAR Scleroderma Trial and Research substudy were asked to recruit patients consecutively.Of the 130 men studied, only 23 (17.7%) had a normal International Index of Erectile Function-5 score. Thirty-eight per cent of all participants had severe ED (International Index of Erectile Function-5 score ¡Ü 7). Men with ED were significantly older than subjects without ED (54.8 years vs. 43.3 years, P < 0.001) and more frequently had simultaneous non-SSc-related risk factors such as alcohol consumption. In 82% of SSc patients, the onset of ED was after the manifestation of the first non-Raynaud's symptom (median delay 4.1 years). ED was associated with severe cutaneous, muscular or renal involvement of SSc, elevated pulmonary pressures and restrictive lung disease. ED was treated in only 27.8% of men. The most common treatment was sildenafil, whose efficacy is not established in ED of SSc patients.Severe ED is a common and early problem in men with SSc. Physicians should address modifiable risk factors actively. More research into the pathophysiology, longitudinal development, treatment and psychosocial impact of ED is needed.Systemic sclerosis (SSc) is a connective tissue disorder in which vascular alterations and endothelial damage are prominent and lead to progressive and widespread dysfunction of various organs. Vascular symptoms such as Raynaud's phenomenon, digital ulcers and pulmonary arterial hypertension are also a frequent target of diagnostic and therapeutic efforts [1]. Men with SSc may develop erectile dysfunction (ED), a vascular complication that is not frequently addressed in studies. Owing to the predominance of the female gender in SSc, studies of ED in SSc men are more dif
%U http://arthritis-research.com/content/14/1/R37